Search Results 871-880 of 18134 for monoclonal antibody
... monoclonal antibody therapy must have completed that therapy ≥ 6 weeks (or 3 half-lives of the antibody, whichever is shorter) prior to enrollment on ...
Immune system diseases, such as rheumatoid arthritis or Crohn's disease. Other diseases requiring medicines, called monoclonal antibodies, that are based on the ...
Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...
... monoclonal antibody therapy in solid organ transplant recipients. J Med ... monoclonal antibody escape mutation in a persistently infected ...
One of the clinical trials involves a studyOpens in new tab to evaluate the use of an investigational device to administer ipilimumab, a monoclonal antibody ...
The treatments include IMiDs, proteosome inhibitors, chemotherapy, monoclonal antibodies and stem cell transplantation.To c ... Immunotherapy with monoclonal ...
... monoclonal antibody: Refractory MM is defined as the development of disease progression during therapy with an anti-myeloma regimen or within 60 days of the ...
Mayo staff administered more than 19,000 monoclonal antibody infusions for patients with COVID-. 19. • Mayo Clinic Laboratories, which serves health care ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Giving dendritic cell therapy, cryosurgery and ...
... Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) Rochester, MN. The ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.